Peter Garcia
2013 - PDL BioPharma
In 2013, Peter Garcia earned a total compensation of $633.6K as Vice President and Chief Financial Officer at PDL BioPharma.
Compensation breakdown
| Non-Equity Incentive Plan | $239,850 |
|---|---|
| Salary | $248,182 |
| Stock Awards | $105,000 |
| Other | $40,581 |
| Total | $633,613 |
Garcia received $248.2K in salary, accounting for 39% of the total pay in 2013.
Garcia also received $239.9K in non-equity incentive plan, $105K in stock awards and $40.6K in other compensation.
Rankings
In 2013, Peter Garcia's compensation ranked 8,522nd out of 12,286 executives tracked by ExecPay. In other words, Garcia earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,522 out of 12,286 | 31st |
Division Manufacturing | 3,097 out of 4,614 | 33rd |
Major group Chemicals And Allied Products | 978 out of 1,466 | 33rd |
Industry group Drugs | 745 out of 1,160 | 36th |
Industry Biological Products, Except Diagnostic Substances | 123 out of 200 | 39th |
Source: SEC filing on April 20, 2016.
Garcia's colleagues
We found five more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2013.
2013
John McLaughlin
PDL BioPharma
Chief Executive Officer
2013
Christopher Stone
PDL BioPharma
General Counsel
2013
Danny Hart
PDL BioPharma
Vice President, Business Development
2013
David Montez
PDL BioPharma
Chief Accounting Officer
2013
Caroline Krumel
PDL BioPharma
Former Vice President of Finance and Principal Accounting Officer
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019